Showing results (661-670 of 863) with videos related to

Sort By:
Pageof 87
European Journal of Cancer & Clinical Oncology|August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapyA W Hutcheon, J B Palmer, M Soukop, et al.
Blood|November 1, 1993
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapyP L Amlot, M J Stone, D Cunningham, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.
World Neurosurgery|December 15, 2016
Rare Lesions of the Internal Auditory CanalKentaro Watanabe, Mary In-Ping Huang Cobb, Ali R Zomorodi, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin LigaseKa Yang, Hao Wu, Zhongrui Zhang, et al.
Journal of Consulting and Clinical Psychology|March 14, 2017
Depressive symptoms and gestational length among pregnant adolescents: Cluster randomized control trial of CenteringPregnancy® plus group prenatal careJennifer N Felder, Elissa Epel, Jessica B Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapyK Sugiyama, S Kumar, A Chaudry, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?N R Maisey, M E Hill, A Webb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot studyM P Findlay, M O Leach, D Cunningham, et al.
Pageof 87